{"id":17755,"date":"2026-09-15T15:26:28","date_gmt":"2026-09-15T15:26:28","guid":{"rendered":"https:\/\/veilles-affaires-sociales.fr\/?p=17755"},"modified":"2026-09-15T15:26:28","modified_gmt":"2026-09-15T15:26:28","slug":"inscription-webinaire-promouvoir-un-acces-abordable-aux-nouveaux-medicaments-un-etat-de-la-sante-dans-lue-22-septembre-2026-12-h-00-13-h-00-cet-titre-traduit-en","status":"publish","type":"post","link":"https:\/\/veilles-affaires-sociales.fr\/?p=17755","title":{"rendered":"Inscription \u2013 Webinaire : Promouvoir un acc\u00e8s abordable aux nouveaux m\u00e9dicaments : un \u00e9tat de la sant\u00e9 dans l\u2019UE (22 septembre 2026, 12 h 00\u201313 h 00 CET)\u00a0(titre traduit en fran\u00e7ais par l&rsquo;IA)"},"content":{"rendered":"<p>L\u2019acc\u00e8s aux m\u00e9dicaments fait l\u2019objet de tensions dans l\u2019ensemble de l\u2019Union europ\u00e9enne, en raison de la hausse des prix des nouvelles th\u00e9rapies et de l\u2019augmentation de la demande, qui mettent sous pression les budgets publics. Entre 2020 et 2025, les \u00c9tats membres ont engag\u00e9 des r\u00e9formes \u00e9tendues pour \u00e9largir la couverture, r\u00e9duire le reste \u00e0 charge des patients et pr\u00e9server la capacit\u00e9 d\u2019innovation dans le domaine pharmaceutique.<\/p>\n<p>Les premi\u00e8res observations font \u00e9tat d\u2019am\u00e9liorations en mati\u00e8re d\u2019accessibilit\u00e9 financi\u00e8re et d\u2019efficience, les initiatives nationales s\u2019alignant de plus en plus sur les r\u00e9formes conduites au niveau de l\u2019UE. Toutefois, des lacunes persistent en termes de protection financi\u00e8re des patients, de complexit\u00e9 r\u00e9glementaire et de contraintes de financement.<\/p>\n<p>Dans ce contexte, une rencontre est organis\u00e9e pour examiner les moyens de combler ces \u00e9carts, les arbitrages entre ma\u00eetrise de l\u2019accessibilit\u00e9 financi\u00e8re et maintien d\u2019incitations \u00e0 l\u2019innovation, ainsi que les conditions n\u00e9cessaires pour maintenir et d\u00e9velopper la R&amp;D pharmaceutique en Europe afin de renforcer \u00e0 la fois les r\u00e9sultats de sant\u00e9 et les retomb\u00e9es \u00e9conomiques. Y participent des repr\u00e9sentants de l\u2019European Observatory on Health Systems and Policies (Nicole Mauer, ainsi que les mod\u00e9ratrices Dimitra Panteli et Erica Richardson), de l\u2019OCDE (Federico Pratellesi) et de la Direction g\u00e9n\u00e9rale de la sant\u00e9 et de la s\u00e9curit\u00e9 alimentaire (DG SANTE) de la Commission europ\u00e9enne (Moritz Suppliet). Ces acteurs y contribuent en tant qu\u2019organisations d\u2019analyse et de suivi des syst\u00e8mes de sant\u00e9, d\u2019expertise \u00e9conomique et de r\u00e9gulation europ\u00e9enne en sant\u00e9. (contenu r\u00e9sum\u00e9 en fran\u00e7ais par l&rsquo;IA)\u00a0\u200b<a href=\"https:\/\/eurohealthobservatory.who.int\/news-room\/events\/item\/2026\/09\/22\/default-calendar\/promoting-affordable-access-to-new-medicines-a-state-of-health-in-the-eu-webinar\" target=\"_blank\" class=\"feedzy-rss-link-icon\">Lire la Suite<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>L\u2019acc\u00e8s aux m\u00e9dicaments fait l\u2019objet de tensions dans l\u2019ensemble de l\u2019Union europ\u00e9enne, en raison de la hausse des prix des nouvelles th\u00e9rapies et de l\u2019augmentation de la demande, qui mettent [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":17753,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[212,7,31],"tags":[258,227,226],"class_list":["post-17755","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gestion-des-crises","category-medicaments-et-produits-de-sante","category-politiques-europeennes-sante-social-travail","tag-hera","tag-ia","tag-sources-etrangeres"],"_links":{"self":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts\/17755","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=17755"}],"version-history":[{"count":0,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts\/17755\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/media\/17753"}],"wp:attachment":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=17755"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=17755"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=17755"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}